Abstract
Cognitive deficits in Parkinson’s disease (PD) are now well recognised although the pathophysiological basis of the deficits remains uncertain (reviewed by Brown and Marsden, 1988; Sagar and Sullivan, 1988). The cognitive deficits occur particularly on “executive” tasks, which are known to be sensitive to frontal lobe dysfunction raising the possibility that a frontal lobe disorder is the basis of the majority of the cognitive impairment in the disease. The pathogenesis of the cognitive deficits remains uncertain but most investigators have concentrated on the role of the “complex” loop between the caudate nucleus and prefrontal cortex (De Long et al., 1984). A deficiency of caudate dopamine is regarded as the principal cause of dysfunction within this loop. Another contributing factor may be dopamine deficiency in the ventral tegmental area leading to dysfunction in the mesocortical projections to the frontal cortex (Javoy-Agid and Agid, 1980; Sagar, 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agid Y., Ruberg M., Dubois B., and Javoy-Agid F., 1984, Biochemical substrates of mental disturbances in Parkinson’s disease, Adv. Neurol. 40: 211–218.
Brown R., and Marsden C.D., 1988, Subcortical dementia: the neuropsychological evidence, Neuroscience 25: 363–387.
Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., and Sullivan E.V., 1991, Cognitive impairment in early untreated Parkinson’s disease and its relationship to motor disability, Brain 114: 2095–2122.
Cooper J.A., Sagar H.J., Doherty S.M., Jordan N., Tidswell P., and Sullivan E.V., 1992, Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson’s disease: a follow-up study of untreated patients, Brain 115: 1701–1725.
Cooper J.A., Sagar H.J., Tidswell P. and Jordan N. Slowed cognitive processing on simple and go/no-go reaction time tasks in Parkinson’s disease, Brain, in press.
De Long M.R., Georgopoulos A.P., Crutcher M.D., Mitchell S.J., Richardson R.T., and Alexander G.E., 1984, Functional organization of the basal ganglia: contributions of single-cell recordings, in: “Functions of the Basal Ganglia”, Ciba Foundation Symposium 107, D. Evered and M. O’Connor, eds., Pitman, London, pp 64–82.
Dubois B., Danze F., Pillon B., Cusimano G., Lhermitte F., and Agid Y., 1987, Cholinergic-dependent cognitive deficits in Parkinson’s disease, Ann. Neurol. 22: 26–30.
Fibiger H.C., 1984, The neurobiological substrates of depression in Parkinson’s disease: a hypothesis. Can. J. Neurol. Sci. 11: 105–107.
Javoy-Agid F., and Agid Y., 1980, Is the mesocortical dopamine system involved in Parkinson disease? Neurology, New York 30: 1326–1330.
Lange K.W., Robbins T.W., Marsden C.D., James M., Owen A.M., and Paul G.M., 1992, L-dopa withdrawal in Parkinson’s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology (Berl), 107: 394–404.
Mayeux R., Stern Y., Cote, L., and Williams J.B.W., 1984, Altered serotonin metabolism in depressed patients with Parkinson’s disease, Neurology 34: 642–646.
Pillon B., Dubois B., Cusimano G., Bonnet A., Lhermitte F., and Agid Y.,1989, Does cognitive impairment in Parkinson’s disease result from non-dopaminergic lesions? J. Neurol. Neurosurg. Psychiatry 52: 201–206
Rogers D., Lees A.J., Smith E., Trimble M., and Stern G.M., 1987, Bradyphrenia in Parkinson’s disease and psychomotor retardation in depressive illness, Brain, 110: 761–776.
Sagar H.J., 1985, Brain-behavior relationships in amnesia and dementia, in: “Senile dementia of the Alzheimer type”, J.T. Hutton, A.D. Kenny AD, eds., Alan R Liss, New York, pp 87–104.
Sagar H.J. and Sullivan E.V., 1988, Patterns of cognitive impairment in dementia, in: “Recent Advances in Clinical Neurology”, Vol. 5, C. Kennard, ed, Churchill Livingstone, Edinburgh, p 47–86.
Sagar H.J., Sullivan E.V., Gabrieli J.D.E., Corkin S., and Growdon J.H., 1988, Temporal ordering and short-term memory deficits in Parkinson’s disease, Brain 111: 525–539.
Stern Y., Mayeux R., and Cote L., 1984, Reaction time and vigilance in Parkinson’s disease: possible role of altered norepinephrine metabolism, Arch. Neurol. 41: 1086–1089
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sagar, H.J., Atchison, L., Doherty, S.M., Ball, M.C., Cooper, J.A. (1995). The Contribution of Non-Dopaminergic Pathology to Cognitive, Motor and Affective Disability in Parkinson’s Disease. In: Hanin, I., Yoshida, M., Fisher, A. (eds) Alzheimer’s and Parkinson’s Diseases. Advances in Behavioral Biology, vol 44. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9145-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9145-7_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9147-1
Online ISBN: 978-1-4757-9145-7
eBook Packages: Springer Book Archive